Contact us: hello@hsrmed.com  |  Clinicians: clinics@hsrmed.com

Demo

Home › Who we serve › Kidney and chronic care

For kidney and chronic care programs

See the trend, not just the last result.

For value-based kidney care and chronic disease programs. HSRMed puts home stability next to eGFR and uACR over time, finds patients who are declining fast or missing tests, and helps teams act months earlier.

  • Risk map of your population by eGFR and uACR category
  • Fast-decline worklist for patients losing kidney function quickly
  • Testing gaps: patients with diabetes missing a kidney panel
  • Chronic programs: diabetes, hypertension, heart failure and COPD

The challenge

Chronic disease moves slowly, until it does not

Kidney disease is often silent until late. Many patients start dialysis without having seen a kidney specialist in time.

Silent progression

Kidney function can decline for years without symptoms, and lab results are reviewed one at a time.

Missed testing

Many patients with diabetes do not have both eGFR and uACR tested every year, so risk goes unseen.

Value-based contracts

Kidney care and chronic care programs are paid on outcomes, and need population trends, not single visits.

Sample screen

Kidney risk map, trends and worklist

The view a kidney care program uses to decide where to focus each week.

HSRMed · Kidney care programSample screen · fictional data

Population by kidney risk

1,220 patients with diabetes or hypertension · eGFR × uACR categories

Patients by eGFR and uACR category
eGFR categoryA1
<30 mg/g
A2
30–300
A3
>300
G1 · 90+210429
G2 · 60–893188821
G3a · 45–591647126
G3b · 30–44824931
G4 · 15–29282430
G5 · <156813
Low riskModerateHighVery high

Mary Johnson · 12-month view

Home stability and lab results side by side

HSI
eGFR, mL/min/1.73m²
uACR, mg/g
Worklist
PatientStageeGFR, 12 monthsuACR, 12 monthsHSILast kidney panelNext step
Mary JohnsonG3a A258 → 47 −960 → 162633 weeks agoNephrology referral; review medications
Carlos RiveraG3b A341 → 35 −6380 → 520592 months agoApproaching G4: plan with nephrology
Betty LawsonG2 A272 → 70 −245 → 587514 months agoKidney panel overdue
Ahmed HassanG3a A152 → 51 −118 → 20775 months agoStable; routine follow-up
Joyce MartinG4 A328 → 24 −4610 → 700561 month agoKidney care team: education and planning
Peter NovakG2 A180 → 80 012 → 118216 months agoKidney panel overdue (diabetes)

What HSRMed delivers

Built for kidney and chronic care programs

Population risk map

Every patient placed by eGFR and uACR category, with counts you can click into.

Long-term trends

HSI, eGFR and uACR over months and years in one view, so slow decline becomes visible.

Worklists

Fast decline, approaching stage 4, and testing gaps, refreshed as new labs arrive.

Chronic care programs

The same approach for diabetes, hypertension, heart failure and COPD, with home data between visits.

Lab and EHR integration

Lab results flow in through HL7 FHIR; tasks and referrals go back to the care team.

Contract reporting

Population measures for value-based kidney care and chronic care contracts.

How it works

From population to patient

  1. Connect lab and EHR data

    eGFR, uACR and other results are loaded for the program population.

  2. Map the risk

    Patients are placed by category and trend; fast decliners and testing gaps are listed.

  3. Add home monitoring

    Enrolled patients send daily data, and HSI shows stability between lab draws.

  4. Act and report

    Care teams work the lists; leaders track progress against contract measures.

What you can measure

Program measures

Kidney health testingPatients with diabetes with both eGFR and uACR each year
Timely referralPatients at stage 4 seen by a kidney specialist
Rate of declineAverage change in eGFR per year, by cohort
Planned startsShare of dialysis starts that were planned

Questions

Questions from kidney and chronic care teams

Does HSRMed measure kidney function?

HSRMed displays eGFR and uACR from laboratory results and places them next to home monitoring trends. It does not replace laboratory testing or diagnose kidney disease.

Which categories do you use?

The risk map follows the widely used eGFR (G1 to G5) and albuminuria (A1 to A3) categories, so it matches how kidney teams already think.

Can we use it for other chronic conditions?

Yes. Diabetes, hypertension, heart failure and COPD programs use the same trends, worklists and reporting.

Who uses this view?

Nephrology practices, kidney care organizations, primary care groups and health plans running chronic care programs.

Map your kidney care population

See the risk map and worklists with sample data, then plan a pilot.

Who we serve

Explore other audiences

Back to Who we serve on the home page